Strategic alliance Recent collaboration with Merck Animal Health to market autogenous poultry vaccines in the United States signals a strong channel partner opportunity. Leverage the partnership to position Cambridge Technologies as a trusted OEM vaccine supplier to large poultry integrators and veterinarians.

Custom vaccine positioning Full custom vaccine capabilities including adjuvant options and SoliDose implant delivery create a competitive edge for breeders, feedlots, and livestock operations facing emerging health threats. Target high-value livestock producers and vets needing tailored vaccines.

USDA‑licensed capacity A 37,000-square-foot USDA-licensed manufacturing facility with state-of-the-art fermentation supports scalable production of custom vaccines. Prospect opportunities include mid- to large-scale orders, emergency response contracts, and long-term supply agreements.

Technical leadership Expertise in metagenomics, sequencing, qPCR, culture, and serology positions Cambridge Technologies for value-added diagnostic service partnerships. Propose bundled offerings combining diagnosis, isolate identification, and turnkey vaccine production for faster time-to-protection.

Growth traction Active hiring of veterinarians and scientific leadership along with publicized partnerships indicates accelerating growth. Focus outreach on mid-market poultry producers, veterinarians, and integrators seeking innovative vaccines and reliable supply chains.